Clinical Trial Update: Dexmedtomodine Effect on Agitated Psychotic Patients Suffer COPD

View source ↗

Summary

A completed clinical trial evaluating dexmedetomidine for agitation in psychotic patients with COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Psychotic Disorders

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Tanta University | Conditions: Response of Agitated Patients to Dexmedetomidine | Status: COMPLETED